Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 487 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups
Patents for C07D 487 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups (57,272)
03/2010
03/11/2010US20100063038 Substituted 4-Amino-Pyrrolotriazine Derivatives Useful for Treating Hyper-Proliferative Disorders and Diseases Associated with Angiogenesis
03/11/2010US20100063028 Triazabenzo[E]Azulene Derivatives for the Treatment Of Tumors
03/11/2010US20100063026 Antibacterial quinoline derivatives
03/11/2010US20100063024 Dihydropyrazolopyrimidinone Derivatives
03/11/2010US20100063023 Bicyclic and Tricyclic Substituted 6-Methylidene Carbapenems as Broad Spectrum Beta-Lactamase Inhibitors
03/11/2010CA2736306A1 Pyrido [5, 4-d] pyrimidines as cell proliferation inhibitors
03/11/2010CA2736304A1 Pyrazolopyrimidines and their use for the treatment of cns disorders
03/11/2010CA2735722A1 Isotopically enriched pyrimidin-5-yl acetic acid derivatives as crth2 antagonists
03/11/2010CA2735420A1 Macrocyclic pyrimidines as protein kinase inhibitors
03/11/2010CA2733671A1 Substituted tricyclic acid derivatives as s1p1 receptor agonists useful in the treatment of autoimmune and inflammatory disorders
03/11/2010CA2733533A1 Hedgehog pathway modulators
03/10/2010EP2160392A2 Novel macrocyclic inhibitors of hepatitis c virus replication
03/10/2010EP1863818B1 Acetylenyl-pyrazolo-pvrimidine derivatives as mglur2 antagonists
03/10/2010EP1781296B1 Quinazoline derivatives and their use in the treatment of thrombocythemia
03/10/2010EP1556385B1 Heterocyclocarboxamide derivatives
03/10/2010CN101665496A Method for synthesizing ionic type metal porphyrin
03/10/2010CN101665495A Method for directly synthesizing nickel phthalocyanine crystal by using solvent thermal method
03/10/2010CN101665494A Tailed tetrasulfhydryl porphyrin with carbon chain length of 6
03/10/2010CN101665493A Synthetic method for water-soluble fluorescent tracer
03/10/2010CN100593542C Pyrazolopyrimidinone derivatives as well as preparation method and application thereof
03/09/2010US7674903 Dehydrophenylahistins and analogs thereof and the synthesis of dehydrophenylahistins and analogs thereof
03/09/2010US7674899 Dimeric azacyclic compounds and their use
03/09/2010US7674803 Thiazolypiperidine derivatives as MTP inhibitors
03/09/2010US7674797 2-phenoxy- and 2-phenylsulfonamide derivatives with CCR3 antagonistic activity for the treatment of asthma and other inflammatory or immunological disorders
03/09/2010US7674791 Triazolopyrazines and methods of making and using the same
03/09/2010US7674790 Processes of making and using pharmaceutical formulations of antineoplastic agents
03/09/2010US7674789 Compounds
03/09/2010CA2306313C Dipeptide nitriles
03/09/2010CA2228847C Ibogamine congeners
03/04/2010WO2010025073A1 Dihydroimidazo [ 1, 5-f] pteridines as polo-like kinase inhibitors
03/04/2010WO2010024258A1 Ring-fused azole derivative having pi3k-inhibiting activity
03/04/2010WO2010023480A1 Saturated bicyclic heterocyclic derivatives as smo antagonists
03/04/2010WO2010022831A1 Explosive
03/04/2010WO2009156951A3 5,6,7,8-tetrahydro-imidazo[1,5-a]pyrazine compounds
03/04/2010WO2009156860A3 4-(pyridin-4-yl)-1h-(1, 3, 5)triazin-2-one derivatives as gsk3-beta inhibitors for the treatment of neurodegenerative diseases
03/04/2010WO2009143211A3 Salts of 2-fluoro-n-methyl-4-[7-(quinolin-6-yl-methyl)- imidazo[1,2-b][1,2,4]triazin-2-yl]benzamide and processes related to preparing the same
03/04/2010US20100056785 Preparation Of Zopiclone And Its Enantiomerically Enriched Isomer
03/04/2010US20100056550 Tricyclic heteroaromatic compounds as dipeptidyl peptidase-iv inhibitors for the treatment or prevention of diabetes
03/04/2010US20100056529 Substituted triazolo-pyridazine derivatives
03/04/2010US20100056506 Substituted 2-amino-fused heterocyclic compounds
03/04/2010US20100056502 Compounds
03/04/2010US20100056499 3-amino-1-arylpropyl azaindoles and uses thereof
03/04/2010US20100056495 Dimeric iap inhibitors
03/04/2010US20100056371 Use of Azolopyrimidines for Controlling Phytopathogenic Harmful Fungi
03/04/2010DE102008045192A1 Sprengstoff Explosive
03/04/2010CA2735177A1 Saturated bicyclic heterocyclic derivatives as smo antagonists
03/03/2010EP2159227A1 Two-photon absorption material and application thereof
03/03/2010EP2158204A2 Heterocyclically substituted heterocyclyl carboxylic acid derivatives
03/03/2010EP2016064B1 Methods for the preparation of pyrazole-containing compounds
03/03/2010EP1541575B1 Novel process for producing imidazo(1,2-b)pyridazine derivative
03/03/2010EP1226153B1 Fluorescent cobalamins and uses thereof
03/03/2010EP1100801B1 Use of cysteine derivatives for preparing a medicine for treating pathologies resulting from the formation of heterotrimeric g protein
03/03/2010CN101663307A 3,4 diaminopyridine derivatives
03/03/2010CN101663306A 2 -heteroaryl- pyrrolo [3, 4-c] pyrrole derivatives and their use as scd inhibitors
03/03/2010CN101663305A 2-amin0-5, 7-dihydr0-6H- pyrrolo [3, 4-D] pyrimidine derivatives as HSP-90 inhibitors for treating cancer
03/03/2010CN101659666A Method for synthesizing copper phthalocyanine crystals by copper powder directly
03/02/2010US7671203 Method and system for separation and purification of at least one narcotic alkaloid using reverse phase preparative chromatography
03/02/2010US7671199 dual inhibitor of VEGFR and FGFR tyrosine kinases; cancer
03/02/2010US7671196 Synthesis of vabicaserin, vabicaserin hydrochloride and derivatives by reacting by reacting a 2,3,3A,4,5,9b-hexahydro-1H-cyclopenta(c)quinoline with a chiralagent, 2-methyl-2-oxazoline; decyclization; alkylation; blocking and deblocking; 5-HT2C agonism; schiophrenia
03/02/2010US7671194 Method of preparing naphthalocyanines
03/02/2010US7671064 angiogenesis inhibitors; as antitumor agents; kinase inhibitors like vascular endothelial growth factor receptors antagonists
03/02/2010US7671059 (S)-2-Amino-6-benzyl-7-[4-fluoro-2-(2-fluoro-pyridin-3-yl)-phenyl]-4-methyl-7,8-dihydro-6H-pyrido[4,3-d]pyrimidin-5-one;cellular proliferative, viral, autoimmune, cardiovascular, and central nervous system diseases
03/02/2010US7671054 Reverse-turn mimetics and method relating thereto
03/02/2010US7671050 (4-Methoxyphenyl)-[3-(4-methoxyphenyl)-[1,2,4]triazolo[3,4-a]phthalazin-6-yl]-amine; phosphodiesterase inhibitors
03/02/2010US7671049 1-{3-[(6-amino-5-nitropyridin-2-yl)amino]propyl}-4-(2,4-dichlorophenyl)-N-[(1S)-2-hydroxy-1-methylethyl]-1H-pyrrole-3-carboxamide; Antidiabetic, hypotensive, antiischemic, anticarcinogenic agents; Alzheimer*s disease, obesity, polycystic ovary syndrome; brain, neurodegenerative and autoimmune diseases
03/02/2010US7671048 gamma-aminobutyric acid GABA receptors inverse agonists ; Alzheimer's disease, cognition enhancers; cyclopropyl-[3-fluoro-9H-imidazo[1,5-a][1,2,4]triazolo[1,5-d][1,4]benzodiazepin-10-yl]-methanone,
03/02/2010US7671047 Cationically substituted diphenylazetidinones, process for their preparation, medicaments comprising these compounds, and their use
03/02/2010US7671046 Target Atp binding sites; ruthenium and platinum are fused to nitrogen heterocyclic ligands; stability and selectivity; anticancer agents
03/02/2010US7671032 19-(7-Methoxy-2-phenyl-quinolin-4-yloxy)-2, 16-dioxo-3,15,17-triaza-tricyclo[15.3.0.0*4,6*]icos-7-ene-4,14-dicarboxylic acid 4-ethyl ester 14-methyl ester, for example; inhibits the NS3 protease of flavivirus such as hepatitis C virus (HCV)
02/2010
02/25/2010WO2010022307A2 Prolyl hydroxylase inhibitors
02/25/2010WO2010022240A1 Pyrrolo [ 1, 2 -b] pyridazine derivatives and their use as hif modulators
02/25/2010WO2010022201A2 Folinic acid derivatives for promoting bone growth
02/25/2010WO2010021934A2 Azaindole inhibitors of iap
02/25/2010WO2010021905A1 Process for preparing polymorph of 7-chloro-n, n,5-trimethyl-4-oxo-3-phenyl-3,5-dihydr0-4h-pyridazin0[4,5-b]indole-1-acetamide
02/25/2010WO2010020905A1 Pyrrolo[2,3-d]pyrimidine compounds
02/25/2010WO2010020675A1 Pyrrolopyrimidine compounds as cdk inhibitors
02/25/2010WO2010020000A1 Novel compounds and their uses in diagnosis
02/25/2010WO2010019976A2 Porphyrins and metalloporphyrins
02/25/2010WO2009158571A8 Heteroaryl compounds and uses thereof
02/25/2010WO2009141288A3 Switchable special effect substances
02/25/2010US20100048897 Process for the preparation of sildenafil and intermediates thereof
02/25/2010US20100048896 Process for the manufacture of a crystalline pyrazolo[1,5-a]pyrimidine compound
02/25/2010US20100048893 Substituted arylalkanoic acid derivatives and use thereof
02/25/2010US20100048829 Ionic liquids for solubilizing polymers
02/25/2010US20100048600 such as trans-2-[3'-oxospiro [cyclohexane- 1,1'(3'H)-isobenzofuran]-4yl]-5-(2-pyridyl) imidazo[4,5-b]pyridine, exhibiting neuropeptide Y antagonistic effects, used for the treatment of cardiovascular, nervous system, metabolic, gastrointestinal, sexual and respiratory system disorders; pharmacokinetics
02/25/2010US20100048590 N-(3-amino-2-hydroxy-propyl) substituted alkylamide compounds
02/25/2010US20100048583 Novel Heterocyclic NF-kB Inhibitors
02/25/2010US20100048575 Novel tetracyclic inhibitors of cysteine proteases, the pharmaceutical compositions thereof and their therapeutic applications
02/25/2010US20100048540 Heterocyclic N-Oxides as Hypoxic Selective Protein Kinase Inhibitors
02/25/2010US20100048528 Heterocyclic compounds as inhibitors of beta-lactamases
02/25/2010US20100047477 6,7-Dihydrobenzimidazo[1,2-c]Quinazolin-6-One Carboxylic Acids, their Esters, and Methods of Synthesis Thereof
02/25/2010US20100047367 Compounds and methods for their use
02/25/2010US20100047178 Perylenequinone derivatives and uses thereof
02/25/2010CA2734802A1 Pyrrolopyrimidine compounds as cdk inhibitors
02/25/2010CA2734448A1 Process for preparing polymorph of 7-chloro-n, n,5-trimethyl-4-oxo-3-phenyl-3,5-dihydr0-4h-pyridazin0[4,5-b]indole-1-acetamide
02/25/2010CA2733359A1 Pyrrolo[2,3-d]pyrimidine compounds
02/25/2010CA2732969A1 Novel compounds and their uses in diagnosis
02/25/2010CA2730357A1 Azaindole inhibitors of iap
02/24/2010EP2157093A1 Pyrrolo-nitrogenous heterocyclic derivatives, the preparation and the pharmaceutical use thereof
02/24/2010EP2157092A1 Remedy for diabetes
1 ... 151 152 153 154 155 156 157 158 159 160 161 162 163 164 165 166 167 168 169 170 171 ... 573